Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms?

被引:11
作者
Jen, Ya-Wen [1 ]
Hwang, Tzung-Jeng [2 ,3 ]
Chan, Hung-Yu [2 ,3 ,4 ]
Hsieh, Ming H. [2 ,3 ]
Liu, Chen-Chung [2 ,3 ]
Liu, Chih-Min [2 ,3 ]
Hwu, Hai-Gwo [2 ,3 ]
Kuo, Ching-Hua [5 ]
Lin, Yi-Ting [2 ,3 ]
Chien, Yi-Ling [2 ,3 ]
Chen, Wei J. [1 ,2 ,3 ,6 ,7 ]
机构
[1] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan
[2] Natl Taiwan Univ, Coll Med, Dept Psychiat, Taipei, Taiwan
[3] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Taipei, Taiwan
[4] Minist Hlth & Welf, Taoyuan Psychiat Ctr, Taoyuan, Taiwan
[5] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei, Taiwan
[6] Natl Taiwan Univ, Ctr Genom, Taipei, Taiwan
[7] Natl Hlth Res Inst, Ctr Neuropsychiat Res, 17 Xu Zhou Rd, Miaoli 100, Taiwan
关键词
Aripiprazole; Prolactin; Psychotic rebound; Biomarker; Schizophrenia; DOUBLE-BLIND; INDUCED HYPERPROLACTINEMIA; PLASMA PROLACTIN; SERUM PROLACTIN; PARTIAL AGONIST; RISPERIDONE; EFFICACY; SAFETY; HALOPERIDOL; 1ST-EPISODE;
D O I
10.1186/s12888-020-02957-7
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
BackgroundSwitching to aripiprazole from other antipsychotics can avoid antipsychotic-induced hyperprolactinemia but may result in an abnormally low prolactin level. This study aimed to assess whether the aripiprazole-induced abnormally low prolactin level was a biomarker for subsequent rebound of positive symptoms in schizophrenia patients.MethodsParticipants were 63 patients in an 8-week trial of switching to aripiprazole, in which preswitching antipsychotics were maintained for the first 2weeks and aripiprazole was fixed at 15mg orally throughout the trial. A prolactin level of <3.7ng/ml was defined as abnormally low, and an increase of two or more points in the positive subscore of the Positive and Negative Syndrome Scale at two adjacent ratings was defined as a psychotic rebound.ResultsAmong 63 patients, 25 (39.7%) had an abnormally low prolactin level and 21 (33.3%) had a psychotic rebound after switching to aripiprazole. In patients with abnormally low prolactin levels, 48.0% of them had a rebound in psychotic symptoms, whereas in those without abnormally low prolactin levels 23.7% did so. Multivariable logistic regression analysis with adjustment for sex, early age at onset, and preswitching medications revealed that abnormally low prolactin levels were associated with psychotic rebound (adjusted odds ratio=3.55, 95% confidence interval=1.02, 12.5). Furthermore, there was concurrency between the trend of the cumulative proportion of patients having an abnormally low prolactin level and that of the cumulative proportion of patients having a rebound in psychotic symptoms.ConclusionsAn abnormally low prolactin level after switching to aripiprazole in schizophrenia patients was a potential warning sign of a psychotic rebound. Hence, monitoring of prolactin levels after switching to aripiprazole may help avoid such rebound in schizophrenia.Trial registrationNCT00545467; Date of registration: 17/10/2007.
引用
收藏
页数:10
相关论文
共 41 条
[1]   Inverse correlation between hallucinations and serum prolactin in patients with non-affective psychoses [J].
Appleberg, B ;
Katila, H ;
Rimón, R .
SCHIZOPHRENIA RESEARCH, 2000, 44 (03) :183-186
[2]  
Bhattacharjee J, 2008, COCHRANE DATABASE SY
[3]   The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements [J].
Buchanan, Robert W. ;
Kreyenbuhl, Julie ;
Kelly, Deanna L. ;
Noel, Jason M. ;
Boggs, Douglas L. ;
Fischer, Bernard A. ;
Himelhoch, Seth ;
Fang, Beverly ;
Peterson, Eunice ;
Aquino, Patrick R. ;
Keller, William .
SCHIZOPHRENIA BULLETIN, 2010, 36 (01) :71-93
[4]   Efficacy and safety of aripiprazole in the acute treatment of schizophrenia in Chinese patients with risperidone as an active control: A Randomized trial [J].
Chan, Hung-Yu ;
Lin, Wei-Wen ;
Lin, Shih-Ku ;
Hwang, Tzung-Jeng ;
Su, Tung-Ping T. ;
Chiang, Shu-Chuan ;
Hwu, Hai-Gwo .
JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (01) :29-36
[5]   Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study [J].
Chen, Jing-Xu ;
Su, Yun-Ai ;
Bian, Qing-Tao ;
Wei, Li-He ;
Zhang, Rong-Zhen ;
Liu, Yan-Hong ;
Correll, Christoph ;
Soares, Jair C. ;
Yang, Fu-De ;
Wang, Shao-Li ;
Zhang, Xiang-Yang .
PSYCHONEUROENDOCRINOLOGY, 2015, 58 :130-140
[6]  
Cheng J.J., 1996, Chinese Psychiatry, V10, P251
[7]   Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy [J].
Chouinard, Guy ;
Samaha, Anne-Noel ;
Chouinard, Virginie-Anne ;
Peretti, Charles-Siegfried ;
Kanahara, Nobuhisa ;
Takase, Masayuki ;
Iyo, Masaomi .
PSYCHOTHERAPY AND PSYCHOSOMATICS, 2017, 86 (04) :189-219
[8]   Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis [J].
Cookson, John ;
Hodgson, Richard ;
Wildgust, Hiram J. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2012, 26 (S5) :42-51
[9]  
FARAONE SV, 1987, J CLIN PSYCHIAT, V48, P151
[10]   HORMONAL EFFECTS OF APOMORPHINE IN SCHIZOPHRENIA [J].
FERRIER, IN ;
JOHNSTONE, EC ;
CROW, TJ .
BRITISH JOURNAL OF PSYCHIATRY, 1984, 144 (APR) :349-357